Compare Solaredge Technologies Inc (SEDG) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Solaredge Technologies Inc vs Zimmer Biomet Holdings Inc — how do they compare? Solaredge Technologies Inc trades at $32.31 (market cap $2.05B), while Zimmer Biomet Holdings Inc trades at $96.28 (market cap $18.55B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 9× Solaredge Technologies Inc's market cap, and Zimmer Biomet Holdings Inc pays a 0.99% dividend while Solaredge Technologies Inc pays none. Which is the better fit depends on your goals.
| SEDG | ZBH | |
|---|---|---|
Market Cap | $2.05B | $18.55B |
Sector | Technology | Health |
52-Week High | $78.51 | $107.71 |
52-Week Low | $25.10 | $79.58 |
Enterprise Value | $1.91B | $25.61B |
Dividend Yield | — | 0.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SolarEdge Technologies (SEDG) trades at $32.34, up 0.4% on the day, amid a challenging period marked by negative profitability and a bearish technical signal. Recent Q2 2026 earnings beat expectations with a surprise profit, but weak Q3 guidance and a net loss under GAAP accounting highlight ongoing struggles. The stock faces headwinds from soft U.S. residential demand and policy dependency, while European growth offers some offset. Analyst sentiment is mixed, with a consensus price target of $35.15 but a majority hold rating reflecting execution risks.
The outlook remains cautious due to persistent losses, high debt, and volatile cash flows. Investment opportunity hinges on margin recovery and policy support, but risks include competitive pressures, liquidity concerns, and macroeconomic sensitivity. Near-term performance will depend on Q3 results and U.S. market trends.
ZBH trades at $96.04, down 1.78% today, with a bullish technical signal from moving averages and a consensus analyst price target of $103.56. Recent Q2 2026 earnings beat expectations with EPS of $2.07 versus $2.01 expected, and the company raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23 billion and a net income margin of 8.56%.
The outlook is positive given earnings momentum and raised guidance, but risks include competitive pressures and debt levels, with the debt-to-asset ratio rising to 32.57% in 2025. Analyst sentiment is mixed with 40% buy ratings, offering a potential 7.8% upside to the consensus target, though investors should monitor margin trends and debt management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Solaredge Technologies Inc
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers. Additionally, the company has nonsolar products targeting energy storage and e-mobility.
Read more on SEDG →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
